258 related articles for article (PubMed ID: 25822043)
1. Impact of Japanese regulatory action on metformin-associated lactic acidosis in type II diabetes patients.
Hanatani T; Sai K; Tohkin M; Segawa K; Saito Y
Int J Clin Pharm; 2015 Jun; 37(3):537-45. PubMed ID: 25822043
[TBL] [Abstract][Full Text] [Related]
2. Risk of lactic acidosis or elevated lactate concentrations in metformin users with renal impairment: a population-based cohort study.
Eppenga WL; Lalmohamed A; Geerts AF; Derijks HJ; Wensing M; Egberts A; De Smet PA; de Vries F
Diabetes Care; 2014 Aug; 37(8):2218-24. PubMed ID: 24842984
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of lactic acidosis in type 2 diabetes patients with metformin in Japan.
Chang CH; Sakaguchi M; Dolin P
Pharmacoepidemiol Drug Saf; 2016 Oct; 25(10):1196-1203. PubMed ID: 27221971
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.
Sipahi S; Solak Y; Acikgoz SB; Genc AB; Yildirim M; Yilmaz U; Nalbant A; Tamer A
Int Urol Nephrol; 2016 Aug; 48(8):1305-1312. PubMed ID: 27102431
[TBL] [Abstract][Full Text] [Related]
5. Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes.
Lee EY; Hwang S; Lee YH; Lee SH; Lee YM; Kang HP; Han E; Lee W; Lee BW; Kang ES; Cha BS; Lee HC
Yonsei Med J; 2017 Mar; 58(2):312-318. PubMed ID: 28120561
[TBL] [Abstract][Full Text] [Related]
6. Lactate levels and risk of lactic acidosis with metformin in diabetic kidney disease patients.
Bipi PK; George J; Gomathy S; Gracious N; Kumar S; Mohandas MK
Saudi J Kidney Dis Transpl; 2017; 28(6):1356-1361. PubMed ID: 29265047
[TBL] [Abstract][Full Text] [Related]
7. Adverse event notifications implicating metformin with lactic acidosis in Australia.
Huang W; Castelino RL; Peterson GM
J Diabetes Complications; 2015; 29(8):1261-5. PubMed ID: 26104729
[TBL] [Abstract][Full Text] [Related]
8. Metformin associated lactic acidosis: incidence and clinical correlation with metformin serum concentration measurements.
van Berlo-van de Laar IR; Vermeij CG; Doorenbos CJ
J Clin Pharm Ther; 2011 Jun; 36(3):376-82. PubMed ID: 21545617
[TBL] [Abstract][Full Text] [Related]
9. Lactic acidosis: relationship between metformin levels, lactate concentration and mortality.
Boucaud-Maitre D; Ropers J; Porokhov B; Altman JJ; Bouhanick B; Doucet J; Girardin E; Kaloustian E; Lassmann Vague V; Emmerich J
Diabet Med; 2016 Nov; 33(11):1536-1543. PubMed ID: 26882092
[TBL] [Abstract][Full Text] [Related]
10. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2002; (2):CD002967. PubMed ID: 12076461
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: A GoDarts study.
Connelly PJ; Lonergan M; Soto-Pedre E; Donnelly L; Zhou K; Pearson ER
Diabetes Obes Metab; 2017 Nov; 19(11):1579-1586. PubMed ID: 28432751
[TBL] [Abstract][Full Text] [Related]
12. Metformin accumulation without hyperlactataemia and metformin-induced hyperlactataemia without metformin accumulation.
Lalau JD; Azzoug ML; Kajbaf F; Briet C; Desailloud R
Diabetes Metab; 2014 Jun; 40(3):220-3. PubMed ID: 24417956
[TBL] [Abstract][Full Text] [Related]
13. Risk of Metformin-Associated Lactic Acidosis (MALA) in Patients After Gastric Bypass Surgery.
Deden LN; Aarts EO; Aelfers SCW; van Borren MMGJ; Janssen IMC; Berends FJ; de Boer H
Obes Surg; 2018 Apr; 28(4):1080-1085. PubMed ID: 29058235
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy in patients with chronic kidney disease.
Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
[TBL] [Abstract][Full Text] [Related]
15. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2003; (2):CD002967. PubMed ID: 12804446
[TBL] [Abstract][Full Text] [Related]
16. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter SR; Greyber E; Pasternak GA; Salpeter Posthumous EE
Cochrane Database Syst Rev; 2010 Jan; (1):CD002967. PubMed ID: 20091535
[TBL] [Abstract][Full Text] [Related]
17. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Salpeter S; Greyber E; Pasternak G; Salpeter E
Cochrane Database Syst Rev; 2006 Jan; (1):CD002967. PubMed ID: 16437448
[TBL] [Abstract][Full Text] [Related]
18. Risk of lactic acidosis in type 2 diabetes patients using metformin: A case control study.
Aharaz A; Pottegård A; Henriksen DP; Hallas J; Beck-Nielsen H; Lassen AT
PLoS One; 2018; 13(5):e0196122. PubMed ID: 29738540
[TBL] [Abstract][Full Text] [Related]
19. Limitations of metformin use in patients with kidney disease: are they warranted?
Vasisht KP; Chen SC; Peng Y; Bakris GL
Diabetes Obes Metab; 2010 Dec; 12(12):1079-83. PubMed ID: 20977579
[TBL] [Abstract][Full Text] [Related]
20. Lactic Acidosis in Diabetic Population: Is Metformin Implicated? Results of a Matched Case-Control Study Performed on the Type 2 Diabetes Population of Grenoble Hospital University.
Lepelley M; Giai J; Yahiaoui N; Chanoine S; Villier C
J Diabetes Res; 2016; 2016():3545914. PubMed ID: 27034959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
